EF
CLVS

Empowered Funds’s Clovis Oncology, Inc. CLVS Stock Holding History

Empowered Funds’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,153
Closed -$1.14M – 130
2017
Q2 		$1.14M Buy
12,153
+541
+5% +$33.1K 0.92% 45
2017
Q1 		$739K Buy
+11,612
New +$706K 0.76% 48

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Empowered Funds's CLVS Position: Q3 2017 in Review

Empowered Funds sold out of Clovis Oncology, Inc. (CLVS) in Q3 2017, closing a stake of 12,153 shares — an estimated $1.14M sold.

Empowered Funds first reported a position in CLVS in Q1 2017 and held it in 2 quarters. The position peaked at $1.14M in Q2 2017. 255 funds tracked by Wall St. Rank hold CLVS as of Q3 2017.

  • Empowered Funds reported no remaining Clovis Oncology, Inc. position as of Q3 2017 after selling out during the quarter.
  • Empowered Funds sold 12,153 Clovis Oncology, Inc. shares in Q3 2017, an estimated $1.14M.
  • Empowered Funds first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 2 quarters.
  • Empowered Funds's Clovis Oncology, Inc. position peaked at $1.14M in Q2 2017.
  • 255 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2017.

Based on Empowered Funds's 13F filing for Q3 2017, filed 31 Oct 2017.